Newborn Screening Market Trends and Share (2020-2030)
The newborn screening market size is projected to reach US$ 2,484.16 million by 2030 from US$ 1,206.74 million in 2022. The market is expected to register a CAGR of 9.40% during 2022–2030. Integration of machine learning and artificial intelligence (AI) in screening will likely remain a key trend in the market.
Newborn Screening Market Analysis
The market is expected to grow due to increased public and healthcare provider awareness of the value of early diagnosis and intervention for newborn disorders through government and nonprofit educational campaigns. Moreover, the need for newborn screening is boosted by increased birth rates, especially in developing nations. Stakeholders in the newborn screening market can improve early detection and intervention and, eventually, improve the health outcomes of newborns globally by utilizing these drivers and opportunities.
Newborn Screening Market Overview
Governments of different countries are increasingly allocating funds for newborn screening programs. These programs help reduce long-term healthcare costs for children and their parents, as congenital and genetic disorders could result in severe health complications and extensive medical interventions if left undetected. By identifying and addressing health issues in infancy, governments can enhance the health and well-being of their citizens. Thus, newborn screening aligns with broader public health objectives to improve overall population health and reduce the burden on healthcare systems.
Government funding promotes equity in healthcare access, ensuring that newborn screening services are available to all, regardless of socioeconomic status. This inclusivity is essential for early disease detection and intervention, as it prevents disparities in healthcare outcomes among different demographic groups. As governments continue prioritizing newborn screening through increased funding and policy support, the infant screening market has been experiencing sustainable growth worldwide.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Newborn Screening Market: Strategic Insights
Market Size Value in US$ 1,206.74 million in 2022 Market Size Value by US$ 2,484.16 million by 2030 Growth rate CAGR of 9.4% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Newborn Screening Market: Strategic Insights
| Market Size Value in | US$ 1,206.74 million in 2022 |
| Market Size Value by | US$ 2,484.16 million by 2030 |
| Growth rate | CAGR of 9.4% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Newborn Screening Market Drivers and Opportunities
Rising Burden of Congenital Diseases Leads to an Increase in Demand for Newborn Screening, Favors the Market Growth
Congenital diseases can lead to lifelong health challenges if not detected and managed early. These diseases can contribute to long-term disability, significantly affecting families, individuals, healthcare systems, and societies. The WHO estimates that 240,000 newborns worldwide succumb to death each year within 28 days of birth due to these diseases. An additional 170,000 children die between the ages of 1 month and five years due to congenital diseases. A growing understanding of the genetic basis of many congenital diseases is one of the several factors contributing to the increasing burden of these conditions. Genomics and genetic testing advancements have enabled healthcare providers to identify a broader range of genetic mutations and conditions in newborns. This expanded knowledge has highlighted the importance of early diagnosis through newborn screening to initiate timely interventions and treatments.
Changing demographics such as maternal age, environmental exposures, and altering lifestyle habits increase the risk of congenital conditions in newborns. Moreover, the number of births occurring every day is on the rise due to the burgeoning global population, resulting in an expanding pool of infants that can be at risk of congenital diseases. In addition, healthcare systems and policymakers recognize the long-term benefits of early disease detection. They increasingly incorporate newborn screening into routine healthcare protocols and insurance coverage, further stimulating market growth. The rising burden of congenital diseases is a significant driver behind the development of the newborn screening market.
Advancements in Methods for Screening Infants for Genetic Disorders hold Immense Potential for the Overall Newborn Screening Market
The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. The US FDA licensed the Kymriah gene therapy in 2017 for use in pediatric patients with a particular kind of acute lymphoblastic leukemia. During this therapy, a new gene that codes for a chimeric antigen receptor is inserted into the patient's T cells, stimulating the altered T cells to go after and destroy the leukemic cells. Yescarta and Zynteglo are two more examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth paved the way for personalized healthcare, aligning with the broader trend of precision medicine.
Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia and aids in an effective preimplantation genetic diagnosis. Recent advancements in genetic tests include non-invasive procedures such as the cell-free fetal DNA approach using maternal plasma. The embryonic DNA can be distinguished from maternal DNA pieces based on size differences. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or massive targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This will allow doctors to provide early molecular interventions with specific pharmacological therapies (pharmacogenetics) and transform cells, tissues, and organs physically and chemically if this genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.
Newborn Screening Market Report Segmentation Analysis
Key segments that contributed to the derivation of the newborn screening market analysis are product type, technology, test type, and end user.
- Based on product type, the newborn screening market is divided into reagents and assay kits, and instruments. The reagents and assay kits segment held the most significant market share in 2022.
- By technology, the market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assays, pulse oximetry screening technology, and others. The pulse oximetry screening technology segment held the largest share of the market in 2022.
- By test type, the market is segmented into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and others. The dry blood spot test segment held the largest share of the market in 2022.
- By end user, the market is categorized into hospitals and clinics, and diagnostic laboratories. The hospitals and clinics segment held the largest share of the market in 2022.
Newborn Screening Market Share Analysis by Geography
The geographic scope of the newborn screening market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
The newborn screening market in North America has experienced significant growth in recent years. The demand for newborn screening services has increased significantly with the surging awareness among parents and healthcare professionals about the importance of early screening for identifying and managing congenital disorders. Additionally, improvements in medical technology have been crucial in enhancing newborn screening capabilities—laboratory automation has boosted screening accuracy, speed, and cost-effectiveness. This has made it possible for medical professionals to give thorough newborn screening panels that cover a larger spectrum of genetic and metabolic disorders. Favorable legislation and regulatory measures also benefit the newborn screening market in North America. Many states and provinces have implemented mandatory newborn screening programs, ensuring all infants are screened shortly after birth. For instance, every state in the US offers newborn screening as a public health program; yearly, ~4 million babies are screened under this program for illnesses that aren't often present at the time of delivery. The Texas Department of Health and Human Services began screening newborns for Spinal Muscular Atrophy (SMA) in June 2021.
The rising prevalence of genetic abnormalities and congenital problems has highlighted the significance of newborn screening. The National Institutes of Health has given a researcher from the University at Buffalo a highly competitive R01 grant to lead an international project to significantly increase the accuracy of newborn screening for three rare, frequently fatal genetic diseases.
Further, the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH funds the US$ 3.8 million five-year award. Thus, the newborn screening market in North America is increasing with increased awareness, technological advancements, supportive policies, and the growing prevalence of congenital disorders.
Newborn Screening Market Report Scope
Newborn Screening Market News and Recent Developments
The newborn screening market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the newborn screening market are listed below:
- Rady Children’s Institute for Genomic Medicine (RCIGM) announced a novel program to advance and evaluate the scalability of a diagnostic and precision medicine guidance tool called BeginNGS (pronounced “beginnings”) to screen newborns for approximately 400 genetic diseases that have known treatment options using rapid Whole Genome Sequencing (rWGS). BeginNGS, developed through a research collaboration with Alexion, AstraZeneca’s Rare Disease group; Fabric Genomics; Genomenon; Illumina, Inc.; and TileDB, uses rWGS to diagnose and identify treatment options for genetic conditions before symptoms begin, an advancement over current pediatric uses of rWGS that focus mainly on children who are already critically ill. (Source: Rady Children's Institute for Genomic Medicine, Press Release, June 2022)
Newborn Screening Market Report Coverage and Deliverables
The “Newborn Screening Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
- Newborn screening market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Newborn screening market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Newborn screening market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the newborn screening market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Technology, Test Type, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the newborn screening market in 2022
Key factors driving the market are the increasing burden of congenital diseases leading to an increase in demand for newborn screening and surging government funding for newborn screening.
Integration of machine learning and artificial intelligence (AI) in screening will likely remain a key trend in the market.
LifeCell International Pvt Ltd, Zentech SA, Trivitron Healthcare Pvt Ltd, PerkinElmer Inc, Waters Corp, Bio-Rad Laboratories Inc., Masimo Corp, Natus Medical Inc., Baebies Inc, MRC Holland BV, Medtronic Plc
The market is expected to register a CAGR of 9.40% during 2022–2030.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Newborn Screening Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Newborn Screening Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Government Funding for Newborn Screening
5.1.2 Rising Burden of Congenital Diseases
5.1.3 Increasing Prevalence of Newborn Disorders
5.2 Key Market Restraints
5.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
5.3 Key Market Opportunities
5.3.1 Genetic Screening of Newborns
5.4 Future Trends
5.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
5.5 Impact Analysis:
6. Newborn Screening Market - Global Market Analysis
6.1 Newborn Screening Market Revenue (US$ Mn), 2022 – 2030
7. Global Newborn Screening Market – Revenue and Forecast to 2030 – by Product Type
7.1 Overview
7.2 Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
7.3 Reagents and Assay Kits
7.3.1 Overview
7.3.2 Reagents and Assay Kits: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Global Newborn Screening Market, by Reagents and Assay Kits, 2020–2030 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Global Newborn Screening Market, by Instruments, 2020–2030 (US$ Million)
8. Global Newborn Screening Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Tandem Mass Spectrometry (TMS)
8.3.1 Overview
8.3.2 Tandem Mass Spectrometry (TMS): Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Molecular Assays
8.4.1 Overview
8.4.2 Molecular Assays: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Immunoassays and Enzymatic Assays
8.5.1 Overview
8.5.2 Immunoassays and Enzymatic Assays: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Pulse Oximetry Screening Technology
8.6.1 Overview
8.6.2 Pulse Oximetry Screening Technology: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Other Technologies
8.7.1 Overview
8.7.2 Other Technologies: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Newborn Screening Market – Revenue and Forecast to 2030 – by Test Type
9.1 Overview
9.2 Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
9.3 Dry Blood Spot Test
9.3.1 Overview
9.3.2 Dry Blood Spot Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Hearing Screen Test
9.4.1 Overview
9.4.2 Hearing Screen Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Critical Congenital Heart Diseases (CCHD) Test
9.5.1 Overview
9.5.2 Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Other Test Types
9.6.1 Overview
9.6.2 Other Test Types: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
10. Global Newborn Screening Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
11. Newborn Screening Market - Geographical Analysis
11.1 North America Newborn Screening Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.1.3.1 North America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.1.3.2 North America: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.1.4 North America: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.1.5 North America: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.1.6 North America: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.1.6.1 North America Newborn Screening Market, by Country
11.1.6.2 US
11.1.6.2.1 US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.2.2 US: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.1.6.2.2.1 US: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.1.6.2.2.2 US: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.1.6.2.3 US: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.1.6.2.4 US: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.1.6.2.5 US: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.1.6.3 Canada
11.1.6.3.1 Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.3.2 Canada: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.1.6.3.2.1 Canada: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.1.6.3.2.2 Canada: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.1.6.3.3 Canada: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.1.6.3.4 Canada: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.1.6.3.5 Canada: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.1.6.4 Mexico
11.1.6.4.1 Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.4.2 Mexico: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.1.6.4.2.1 Mexico: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.1.6.4.2.2 Mexico: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.1.6.4.3 Mexico: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.1.6.4.4 Mexico: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.1.6.4.5 Mexico: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2 Europe Newborn Screening Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.3.1 Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.3.2 Europe: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.4 Europe: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.5 Europe: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6 Europe: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.1 Europe Newborn Screening Market, by Country
11.2.6.2 UK
11.2.6.2.1 UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.2.2 UK: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.2.2.1 UK: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.2.2.2 UK: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.2.3 UK: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.2.4 UK: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.2.5 UK: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.3 Germany
11.2.6.3.1 Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.3.2 Germany: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.3.2.1 Germany: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.3.2.2 Germany: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.3.3 Germany: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.3.4 Germany: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.3.5 Germany: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.4 France
11.2.6.4.1 France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.4.2 France: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.4.2.1 France: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.4.2.2 France: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.4.3 France: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.4.4 France: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.4.5 France: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.5 Italy
11.2.6.5.1 Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.5.2 Italy: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.5.2.1 Italy: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.5.2.2 Italy: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.5.3 Italy: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.5.4 Italy: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.5.5 Italy: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.6 Spain
11.2.6.6.1 Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.6.2 Spain: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.6.2.1 Spain: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.6.2.2 Spain: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.6.3 Spain: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.6.4 Spain: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.6.5 Spain: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.7 Rest of Europe
11.2.6.7.1 Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.7.2 Rest of Europe: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.7.2.1 Rest of Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.7.2.2 Rest of Europe: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.7.3 Rest of Europe: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.7.4 Rest of Europe: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.7.5 Rest of Europe: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3 Asia Pacific Newborn Screening Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.3.1 Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.3.2 Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6 Asia Pacific: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.1 Asia Pacific Newborn Screening Market, by Country
11.3.6.2 China
11.3.6.2.1 China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.2.2 China: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.2.2.1 China: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.2.2.2 China: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.2.3 China: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.2.4 China: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.2.5 China: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.3 Japan
11.3.6.3.1 Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.3.2 Japan: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.3.2.1 Japan: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.3.2.2 Japan: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.3.3 Japan: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.3.4 Japan: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.3.5 Japan: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.4 India
11.3.6.4.1 India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.4.2 India: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.4.2.1 India: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.4.2.2 India: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.4.3 India: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.4.4 India: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.4.5 India: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.5 Australia
11.3.6.5.1 Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.5.2 Australia: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.5.2.1 Australia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.5.2.2 Australia: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.5.3 Australia: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.5.4 Australia: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.5.5 Australia: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.6 South Korea
11.3.6.6.1 South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.6.2 South Korea: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.6.2.1 South Korea: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.6.2.2 South Korea: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.6.3 South Korea: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.6.4 South Korea: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.6.5 South Korea: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.7 Rest of Asia Pacific
11.3.6.7.1 Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.7.2 Rest of Asia Pacific: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.7.2.1 Rest of Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.7.2.2 Rest of Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.7.3 Rest of Asia Pacific: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.7.4 Rest of Asia Pacific: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.7.5 Rest of Asia Pacific: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.4 Middle East & Africa Newborn Screening Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.4.3.1 Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.4.3.2 Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.4.6 Middle East & Africa: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.4.6.1 Middle East & Africa Newborn Screening Market, by Country
11.4.6.2 Saudi Arabia
11.4.6.2.1 Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.2.2 Saudi Arabia: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.4.6.2.2.1 Saudi Arabia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.4.6.2.2.2 Saudi Arabia: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.4.6.2.3 Saudi Arabia: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.4.6.2.4 Saudi Arabia: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.4.6.2.5 Saudi Arabia: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.4.6.3 UAE
11.4.6.3.1 UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.3.2 UAE: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.4.6.3.2.1 UAE: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.4.6.3.2.2 UAE: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.4.6.3.3 UAE: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.4.6.3.4 UAE: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.4.6.3.5 UAE: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.4.6.4 South Africa
11.4.6.4.1 South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.4.2 South Africa: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.4.6.4.2.1 South Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.4.6.4.2.2 South Africa: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.4.6.4.3 South Africa: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.4.6.4.4 South Africa: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.4.6.4.5 South Africa: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.4.6.5 Rest of Middle East & Africa
11.4.6.5.1 Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.5.2 Rest of Middle East & Africa: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.4.6.5.2.1 Rest of Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.4.6.5.2.2 Rest of Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.4.6.5.3 Rest of Middle East & Africa: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.4.6.5.4 Rest of Middle East & Africa: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.4.6.5.5 Rest of Middle East & Africa: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.5 South & Central America Newborn Screening Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.5.3.1 South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.5.3.2 South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.5.4 South & Central America: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.5.5 South & Central America: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.5.6 South & Central America: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.5.6.1 South & Central America Newborn Screening Market, by Country
11.5.6.2 Brazil
11.5.6.2.1 Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.2.2 Brazil: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.5.6.2.2.1 Brazil: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.5.6.2.2.2 Brazil: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.5.6.2.3 Brazil: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.5.6.2.4 Brazil: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.5.6.2.5 Brazil: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.5.6.3 Argentina
11.5.6.3.1 Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.3.2 Argentina: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.5.6.3.2.1 Argentina: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.5.6.3.2.2 Argentina: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.5.6.3.3 Argentina: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.5.6.3.4 Argentina: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.5.6.3.5 Argentina: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.5.6.4 Rest of South & Central America
11.5.6.4.1 Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.4.2 Rest of South & Central America: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.5.6.4.2.1 Rest of South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.5.6.4.2.2 Rest of South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.5.6.4.3 Rest of South & Central America: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.5.6.4.4 Rest of South & Central America: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.5.6.4.5 Rest of South & Central America: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
12. Newborn Screening Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in Newborn Screening Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 LifeCell International Pvt Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Zentech SA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Trivitron Healthcare Pvt Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PerkinElmer Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Waters Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio-Rad Laboratories Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Masimo Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Natus Medical Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Baebies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 MRC Holland BV
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Medtronic Plc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
List of Tables
Table 1. Newborn Screening Market Segmentation
Table 2. Global Newborn Screening Market, by Reagents and Assay Kits – Revenue and Forecast to 2030 (US$ Million)
Table 3. Global Newborn Screening Market, by Instruments – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. North America Newborn Screening Market, by Test Type– Revenue and Forecast to 2030 (US$ Million)
Table 9. North America Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. US Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 11. US Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. US Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. US Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 14. US Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. US Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 19. Canada Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 20. Canada Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. Canada Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 24. Mexico Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 25. Mexico Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 26. Mexico Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. Mexico Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 29. Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 30. Europe Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 31. Europe Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 32. Europe Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 33. Europe Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 34. UK Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 35. UK Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 36. UK Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 37. UK Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 38. UK Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 39. UK Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 40. Germany Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 41. Germany Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 42. Germany Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 43. Germany Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 44. Germany Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 45. Germany Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 46. France Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 47. France Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 48. France Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 49. France Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 50. France Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 51. France Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 52. Italy Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 53. Italy Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 54. Italy Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 55. Italy Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 56. Italy Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 57. Italy Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 58. Spain Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 59. Spain Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 60. Spain Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 61. Spain Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 62. Spain Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 63. Spain Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 64. Rest of Europe Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 65. Rest of Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 66. Rest of Europe Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 67. Rest of Europe Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 68. Rest of Europe Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Europe Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 70. Asia Pacific Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 71. Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 72. Asia Pacific Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 73. Asia Pacific Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 74. Asia Pacific Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 75. Asia Pacific Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 76. China Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 77. China Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 78. China Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 79. China Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 80. China Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 81. China Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 82. Japan Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 83. Japan Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 84. Japan Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 85. Japan Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 86. Japan Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 87. Japan Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 88. India Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 89. India Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 90. India Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 91. India Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 92. India Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 93. India Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 94. Australia Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 95. Australia Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 96. Australia Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 97. Australia Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 98. Australia Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 99. Australia Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 100. South Korea Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 101. South Korea Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 102. South Korea Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 | (US$ Million)
Table 103. South Korea Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 104. South Korea Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 105. South Korea Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of Asia Pacific Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of Asia Pacific Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of Asia Pacific Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 110. Rest of Asia Pacific Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 111. Rest of Asia Pacific Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 112. Middle East & Africa Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 113. Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 114. Middle East & Africa Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 115. Middle East & Africa Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 116. Middle East & Africa Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 117. Middle East & Africa Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 118. Saudi Arabia Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 119. Saudi Arabia Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 120. Saudi Arabia Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 121. Saudi Arabia Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 122. Saudi Arabia Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 123. Saudi Arabia Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 124. UAE Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 125. UAE Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 126. UAE Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 127. UAE Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 128. UAE Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 129. UAE Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 130. South Africa Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 131. South Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 132. South Africa Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 133. South Africa Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 134. South Africa Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 135. South Africa Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of Middle East & Africa Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 138. Rest of Middle East & Africa Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 139. Rest of Middle East & Africa Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 140. Rest of Middle East & Africa Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 141. Rest of Middle East & Africa Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 142. South & Central America Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 143. South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 144. South & Central America Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 145. South & Central America Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 146. South & Central America Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 147. South & Central America Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 148. Brazil Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 149. Brazil Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 150. Brazil Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 151. Brazil Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 152. Brazil Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 153. Brazil Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 154. Argentina Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 155. Argentina Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 156. Argentina Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 157. Argentina Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 158. Argentina Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 159. Argentina Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 160. Rest of South & Central America Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 161. Rest of South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 162. Rest of South & Central America Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 163. Rest of South & Central America Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 164. Rest of South & Central America Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 165. Rest of South & Central America Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 166. Recent Organic Growth Strategies in Newborn Screening Market
Table 167. Recent Inorganic Growth Strategies in the Newborn Screening Market
Table 168. Glossary of Terms, Newborn Screening Market
List of Figures
Figure 1. Newborn Screening Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Newborn Screening Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Newborn Screening Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Newborn Screening Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 7. Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 8. Reagents and Assay Kits: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Instruments: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 11. Tandem Mass Spectrometry (TMS): Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular Assays: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Immunoassays and Enzymatic Assays: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Pulse Oximetry Screening Technology: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Other Technologies: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 17. Dry Blood Spot Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Hearing Screen Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Other Test Types: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Hospitals and Clinics: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diagnostic Laboratories: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: Newborn Screening Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. North America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 27. US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Europe Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 31. Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Europe Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 33. UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Asia Pacific Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 40. Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Asia Pacific Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 42. China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Middle East & Africa Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 49. Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. Middle East & Africa Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 51. Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. South & Central America Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 56. South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. South & Central America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 58. Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Growth Strategies in Newborn Screening Market
The List of Companies - Newborn Screening Market
- LifeCell International Pvt Ltd
- Zentech SA
- Trivitron Healthcare Pvt Ltd
- PerkinElmer Inc
- Waters Corp
- Bio-Rad Laboratories Inc.
- Masimo Corp
- Natus Medical Inc.
- Baebies Inc
- MRC Holland BV
- Medtronic Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For